227 related articles for article (PubMed ID: 10200340)
1. Altered complex formation between p21waf, p27kip and their partner G1 cyclins determines the stimulatory or inhibitory transforming growth factor-beta1 growth response of human fibroblasts.
Dkhissi F; Raynal S; Lawrence DA
Int J Oncol; 1999 May; 14(5):905-10. PubMed ID: 10200340
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event.
Zancai P; Cariati R; Rizzo S; Boiocchi M; Dolcetti R
Oncogene; 1998 Oct; 17(14):1827-36. PubMed ID: 9778049
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
Salatino M; Labriola L; Schillaci R; Charreau EH; Elizalde PV
Exp Cell Res; 2001 Apr; 265(1):152-66. PubMed ID: 11281653
[TBL] [Abstract][Full Text] [Related]
4. TGF beta-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein.
Herrera RE; Mäkelä TP; Weinberg RA
Mol Biol Cell; 1996 Sep; 7(9):1335-42. PubMed ID: 8885230
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2).
Strutz F; Zeisberg M; Renziehausen A; Raschke B; Becker V; van Kooten C; Müller G
Kidney Int; 2001 Feb; 59(2):579-92. PubMed ID: 11168939
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta-induced activation of cyclin E-cdk2 kinase and down-regulation of p27Kip1 in C3H 10T1/2 mouse fibroblasts.
Ravitz MJ; Yan S; Herr KD; Wenner CE
Cancer Res; 1995 Apr; 55(7):1413-6. PubMed ID: 7882344
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
[TBL] [Abstract][Full Text] [Related]
10. Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in human gastric cancer cells.
Kim SG; Kim SN; Jong HS; Kim NK; Hong SH; Kim SJ; Bang YJ
Oncogene; 2001 Mar; 20(10):1254-65. PubMed ID: 11313870
[TBL] [Abstract][Full Text] [Related]
11. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
Reynisdóttir I; Polyak K; Iavarone A; Massagué J
Genes Dev; 1995 Aug; 9(15):1831-45. PubMed ID: 7649471
[TBL] [Abstract][Full Text] [Related]
12. Growth stimulation of murine fibroblasts by TGF-beta1 depends on the expression of a functional p53 protein.
Dkhissi F; Raynal S; Jullien P; Lawrence DA
Oncogene; 1999 Jan; 18(3):703-11. PubMed ID: 9989820
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of transforming growth factor on cell cycle regulatory molecules in human myeloid leukemia cells.
Hu X; Zhang X; Zhong Q; Fisher AB; Bryington M; Zuckerman KS
Oncogene; 2001 Oct; 20(47):6840-50. PubMed ID: 11687963
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
Orend G; Hunter T; Ruoslahti E
Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134
[TBL] [Abstract][Full Text] [Related]
15. Insensitivity to growth inhibition by TGF-beta1 correlates with a lack of inhibition of the CDK2 activity in prostate carcinoma cells.
Cipriano SC; Chen YQ
Oncogene; 1998 Sep; 17(12):1549-56. PubMed ID: 9794232
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
17. Differential modulation of G1 cyclins and the Cdk inhibitor p27kip1 by platelet-derived growth factor and plasma factors in density-arrested fibroblasts.
Winston J; Dong F; Pledger WJ
J Biol Chem; 1996 May; 271(19):11253-60. PubMed ID: 8626675
[TBL] [Abstract][Full Text] [Related]
18. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
Rao S; Lowe M; Herliczek TW; Keyomarsi K
Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
[TBL] [Abstract][Full Text] [Related]
19. Complex mechanisms underlying impaired activation of Cdk4 and Cdk2 in replicative senescence: roles of p16, p21, and cyclin D1.
Morisaki H; Ando A; Nagata Y; Pereira-Smith O; Smith JR; Ikeda K; Nakanishi M
Exp Cell Res; 1999 Dec; 253(2):503-10. PubMed ID: 10585273
[TBL] [Abstract][Full Text] [Related]
20. Regulation of G(1) cyclin-dependent kinases in the liver: role of nuclear localization and p27 sequestration.
Albrecht JH; Rieland BM; Nelsen CJ; Ahonen CL
Am J Physiol; 1999 Dec; 277(6):G1207-16. PubMed ID: 10600818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
